News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel
Sign In

How to Assess the Potential of Your Hospital or Health Network Laboratory During This Era of Declining Lab Reimbursement, Integrated Care Models, and Personalized Medicine

Dark Daily Webinar – Held Wednesday, August 28, 2019

Please contact us at 512-264-7103 or info@darkreport.com for information

The clinical laboratory industry is increasingly revolving around hospitals, health systems, and other integrated care delivery networks. Laboratories continue to be challenged with reimbursement reductionsvalue-based contracting demandsfinancial outcomes measured as total cost of care, not to mention a demand for complex and costly technologies.

These factors, along with many others, contribute to the need for laboratory directors, and hospital and health system executives to now consider alternatives to traditional practice models, along with the challenge of determining those alternatives which are viable for their particular organization.

This 60-minute program, including an interactive Q&A session, is a must-attend event for every member of the hospital, health system, or lab team responsible for the research and consideration of emerging laboratory business models such as joint ventures, affiliations, and partnership models. You’ll get answers to the tough questions and gain the knowledge you need to make the decisions right for your laboratory—those that will enhance patient care, while enabling fiscal responsibility and ongoing financial success.

You’ll learn how instituting strong medical leadership including physicians, operational leaders, medical technologists, and others— plus preserving onsite clinical expertise, enabling access to external support including innovative reimbursement strategies and technologies, along with the introduction of other key principles, can effectively contribute to your lab’s long-term health and financial sustainability.

Please contact us at 512-26-7103 or info@darkreport.com for information


Attend this program, 
and our speakers will guide you through the following specific strategies:

  • Examine the top 3 market shifts around integrated care delivery that most affect clinical labs
  • Explore the value of joint ventures, affiliations, and externals partnerships and how they can enhance medical care and improve your lab’s bottom line
  • Compare the specific challenges of make vs. outsource vs. partnership business decisions
  • Be able to identify appropriate opportunities for your lab and the associated due diligence considerations
  • Evaluate the factors contributing to a sustainable partnership, including integrating local infrastructure and clinical expertise with external resources and technologies
  • Understand how to apply medical leadership principles to set the foundation for high-quality, cost-effective integrated patient care, and much more!

Who should attend?

  • Laboratory owners and C-suite executives
  • Integrated health system leaders
  • Hospital group leaders
  • Physicians and physician group leaders

Please contact us at 512-26-7103 or info@darkreport.com for information

 

Our expert speakers:

 

Jerry W. Hussong, MD, MBA
Chief Executive Officer
Sonic Healthcare USA
Austin, TX

Paul N. Fiedler, MD
Chair, Department of Pathology and Laboratory Medicine
Western CT Health Network | Danbury Hospital Campus
Western Connecticut Health Network
Danbury, CT

Your registration includes:

  •  A site license to attend the webinar. Invite as many members of your team as you would like!
  • A full transcript emailed to you soon after the conference
  •  For more information, call us at 512-264-7103.

 


THE DARK REPORT WEBINAR AT A GLANCE

DATE:                       Held Wednesday, August 28
TIME:                        1 PM EDT; Noon CDT; 10 AM PDT
PLACE:                     Your computer and/or speakerphone
COST:                        $195 per site (unlimited attendance per site)
TO DOWNLOAD:   Please contact us at 512-26-7103 or info@darkreport.com for information


Speakers:

Jerry Hussong

Jerry W. Hussong, MD, MBA
Chief Executive Officer
Sonic Healthcare USA
Austin, TX

With over 20 years of clinical and administrative laboratory medicine/pathology experience, Jerry Hussong is committed to the enhancement of patient care through his stewardship of medical leadership by fostering expanded partnerships between laboratory services, physicians, and their patients.

Prior to serving as the CEO of Sonic, Dr. Hussong was Chief Medical Officer. Before joining Sonic, he held positions including the CMO/Director of Laboratories of and Director of Hematopathology at Cedars-Sinai Medical. He is boarded in anatomic and clinical pathology as well as hematopathology.

Dr. Hussong has published numerous peer reviewed journal articles and has served on numerous national committees, including the CAP Surgical Pathology and Cancer Committees. He currently sits on the ACLA board.

Paul N. Fiedler, MD

Paul N. Fiedler, MD
Chair, Department of Pathology and Laboratory Medicine
Western CT Health Network | Danbury Hospital Campus
Western Connecticut Health Network
Danbury, CT

In addition to the position of Chair, Department of Pathology & Laboratory Medicine at the Western Connecticut Health Network, Paul Fiedler also holds academic appointments at Yale, the University of Vermont, and Ross University. With 25 years of experience as an attending pathologist, medical educator and inventor of medical tests, Dr. Fiedler leads a team of skilled pathologists, scientists, pathology residents and medical technologists in providing lab services for patients in Western CT and developing novel assays that have promising clinical applications.

Dr. Fiedler has published over 30 papers and numerous abstracts and has been granted nine United States patents. He recently served on the Practice Management Committee for the CAP. In addition, he has provided consultative services to pharmaceutical and diagnostic companies and has been retained as an expert witness in medical-legal proceedings.

;